7,12-dihydroxymethylbenz(a)anthracene has been researched along with nobiletin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, CY; Dushenkov, S; Ho, CT; Lai, CS; Li, S; Lo, CY; Pan, MH; Wang, YJ | 1 |
1 other study(ies) available for 7,12-dihydroxymethylbenz(a)anthracene and nobiletin
Article | Year |
---|---|
Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Benz(a)Anthracenes; Blotting, Western; Carcinogenicity Tests; Cyclooxygenase 2; Electrophoretic Mobility Shift Assay; Female; Flavones; Gene Expression; Immunohistochemistry; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Ornithine Decarboxylase; Proliferating Cell Nuclear Antigen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Skin Neoplasms; Transcription Factor AP-1 | 2008 |